ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest genetic medicine news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks genetic medicine across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Zürich-based Immitra Bio closed an upsized €2.58 million pre-Seed round for its scalable in-vivo genetic medicine platform. Backbone Ventures led the round, co-led by OCCIDENT, with participation from Another VC, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation, and private investors. Non-dilutive funding contributed €161.8k.
Summaries by ByteBrief